Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (354)	2/2/1999 9:45:00 PM
From: scaram(o)uche	Respond to of 613

David: It was pretty important news. I was really hoping for the anxiety program to get a bit further this time. But.... over-reaction?..... NRGN has tons of science, and, like Harry Tracy pointed out elsewhere, they have the expertise to take GABA receptors further, faster, than others. Dr. Tracy indicated that he still thinks that it's over-valued. I think it's under-valued. Now, who are you going to believe?.... he thought that it was over-valued yesterday, and I thought it was under-valued. Ugh. I hate being wrong. Rick